Ischemin (sodium)
Ischemin sodium is a CBP bromodomain inhibitor that inhibits p53 interaction with CBP and transcriptional activity in cells. Ischemin sodium salt inhibits p53-induced p21 activation with an IC50 value of 5 µM. Ischemin sodium salt also prevents apoptosis in ischemic cardiomyocytes. Ischemin sodium salt can be used in the study of cardiovascular diseases (such as myocardial ischemia) [1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; Epigenetic Reader Domain; MDM-2/p53
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics
Applications
Neuroscience-Neurodegeneration
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/ischemin-sodium.html
Purity
99.32
Solubility
H2O : 25 mg/mL (ultrasonic)
Smiles
CC1=CC(/N=N/C2=C(C=C(C(S(=O)(O[Na])=O)=C2)C)C)=C(C=C1O)N
Molecular Formula
C15H16N3NaO4S
Molecular Weight
357.36
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
E-Cadherin (CDH1) / CD324 (Intercellular Junction Marker) (CDH1/2208R), CF594 conjugate, 0.1mg/mL
